Additional Information
Therapeutic class: Anti-neovascularization
Chemical class: Antisens oligonucleotide
Main indication: prevention and treatment of corneal neovascularization
Presentations: 0.86 mg/mL eye drops solution in 60 single-dose containers
Related Products
Disclaimer
Pharma Solution is the marketing agent and Distributor for the listed products for the Gulf and MENA region. The products are either registered and approved by the respective local health authority or contracted by the MAH to supply to the end users on a named patient basis. Some products such as Orphan drugs, rare diseases medicines are imported based on special import permits and as per need of the Hospitals in compliance with full documentation.
